Gunze obtains government approval to produce and sell helmets for infants’ positional skull deformation "ReMO baby®" in subsidiary “Medical U&A” in May 2022 Realizing high quality & quick delivery through in-house production
News
Gunze obtains government approval to produce and sell helmets for infants’ positional skull deformation "ReMO baby®" in subsidiary “Medical U&A” in May 2022 Realizing high quality & quick delivery through in-house production
Osaka-Gunze Limited (Headquarters: Osaka, Japan, President: Toshiyasu Saguchi) [TOKYO: 3002] is pleased to announce that a subsidiary “Medical U&A (hereinafter MUA)” has obtained government approval to produce and sell helmets for infants’ positional skull deformation "ReMO baby®" in Japan on May 26, 2022. Previously, the products were imported from overseas and supplied by MUA. In order to meet the needs of medical professionals, the company has started in-house production, which will enable us to provide high quality products with shorter delivery times.
MUA is a pioneer of cranial reshaping helmet in Japan, having launched the first approval product in 2015. By combining MUA’s accumulated extensive date and knowledge with GUNZE's medical material processing technology, the company has developed a domestic product more suited to Japanese. This has enabled us to provide products with shorter delivery times and higher quality.
About helmet therapy for positional skull deformation
(1) Since the infant's skull is made up of multiple bones loosely connected by fibrous tissue, the bones are movable and the skull itself is soft until around one year of age. Cranial deformity may occur due to continuous pressure on the skull caused by the baby's orientation habit and the way he or she is laid down. (2) This cranial deformity in infants due to external pressure is caused by continuous pressure on the soft skull at 2 to 20 weeks of age, and if left untreated, may be fixed after 12 months of age. (3) Helmet therapy for positional skull deformation is determined by a comprehensive examination and consultation at a medical specialist. (4) In the case the helmet therapy is needed, a medical specialist uses a 3D scanner to obtain data and create a helmet that fits the head of each individual infant. (5) The helmet therapy takes about 5 months on average, and the infant wears it day and night. Based on the observation by medical specialist, size adjustment and the time of completion of helmet therapy will be determined.
Product Features of “ReMO baby”
(1) Accumulated extensive data and knowledge enables fine-tuning of the product Our extensive track record allows us to satisfy the detailed needs of medical professionals and patients. The products can be customized to meet the needs of medical professionals and patients.
(2) Products can be delivered and adjusted in a short period of time Compared to conventional imported products, the Japanese product realizes to deliver and adjust in a shorter period of time, so patients don’t have to wait. (3) Any type of 3D scanner available The data can be used without depending on a specific scanner, so it can meet the needs of almost all medical specialists.
Product outline
Product name
ReMO baby®
Intended use or effect
The device is intended to improve the asymmetry and shape of the infant's cranium with wearing on head.
Approval number
30400BZX00118000
Manufacture
Gunze Limited
Marketing Strategy
In order to meet the needs of medical professionals and patients' families, MUA will launch the product as soon as possible. And the company strives to sales expansion through educating the new product features.
・Sales of medical instruments (Plastic and Reconstructive surgery, Neurosurgery, Oral surgery, Cardiovascular surgery, Cosmetic surgery, Pediatric surgery, Dermatology etc.) ・Consultation for opening medical facilities
Information posted here (product information, market launch date, contact, URL, etc.) is as of release date. Posted information is subject to change without notice.
